Biogen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis.
BIIB Key Statistics
Stock Snapshot
As of today, Biogen(BIIB) shares are valued at $225.88. The company's market cap stands at 33.4B, with a P/E ratio of 40.21.
On 2026-10-01, Biogen(BIIB) stock traded between a low of $225.51 and a high of $229.36. Shares are currently priced at $225.88, which is +0.2% above the low and -1.5% below the high.
Biogen(BIIB) shares are trading with a volume of 1.49M, against a daily average of 1.3M.
During the past year, Biogen(BIIB) stock moved between $138.00 at its lowest and $230.49 at its peak.
During the past year, Biogen(BIIB) stock moved between $138.00 at its lowest and $230.49 at its peak.
BIIB News
Biogen reported two product updates: positive adolescent subgroup results from the Phase 3 VALIANT trial of EMPAVELI in rare kidney diseases and Japanese approv...
Analyst ratings
65%
of 37 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.